Immunoadsorption with tryptophan columns: A therapeutic option for the treatment of Rheumatoid arthritis with septic complications

Journal of Clinical Apheresis

Volumn 24, Issue 1, 2009, Pages 37-41

  Thomaidis, Thomas ^a,b   Schorn, Corinna ^a   Flaig, Wolfram ^a   Lingg, Gerwinn ^a   Schönhas, Elke ^b   Klingel, Reinhard ^c   Galle, Peter R ^b   Schwarting, Andreas ^a,b  

^a SANA KLINIKUM OFFENBACH   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Apheresis Research Institute   (Germany)

Author keywords

Bacterial spondylitis; Immunoadsorption; Rheumatoid arthritis; Tryptophan columns

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; GOLD; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MOXIFLOXACIN; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID; TRYPTOPHAN;

AGED; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE ACTIVITY; DRUG EXPOSURE; DRUG REEXPOSURE; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN; IMMUNOADSORPTION; LABORATORY TEST; LONG TERM CARE; LOW DRUG DOSE; PATIENT SAFETY; RHEUMATOID ARTHRITIS; SPONDYLITIS; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

AGED; ARTHRITIS, RHEUMATOID; BACTERIAL INFECTIONS; HUMANS; IMMUNOSORBENT TECHNIQUES; SEPSIS; SPONDYLITIS; STEROIDS; TREATMENT OUTCOME; TRYPTOPHAN;

EID: 63249127112     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20188     Document Type: Article

References (17)

1. Luqmani R, Hennell S, Estrach C, Birrell F, Bosworth A, Davenport G, Fokke C, Goodson N, Jeffreson P, Lamb E, Mohammed R, Oliver S, Stableford Z, Walsh D, Washbrook C, Webb F. British society for rheumatology and British health professionals in rheumatology guideline for the management of rheumatoid arthritis (The first 2 years). Rheumatology (Oxford) 2006;45:1167-1169.
2. Keller F, Wagner K, Faber U, Scholle J, Neumayer HH, Maiga M, Schultze G, Offermann G, Molzahn M. Elimination kinetics of plasma exchange. Klin Wochenschr 1983;61:1115-1122.
3. Huskisson EC. Measurement of pain. Lancet 1974;2:1127-1131.
4. Prevoo MLL, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum 1995;38:44-48.
5. Snyder HW, Cochran SK, Balint JP Jr., Bertram JH, Mittelman A, Guthrie TH Jr., Jones FR. Experience with protein A-immunoadsorption in treatment-resistant adult immunothrombocytopenic purpura. Blood 1992;79:2237-2245.
6. Snyder HW Jr., Mittelman A, Oral A, Messerschmidt GL, Henry DH, Korec S, Bertram JH, Guthrie TH Jr., Ciavarella D, Wuest D, Perkins W, Balint JP Jr., Cochran SK, Peugeot RL, Jones FR. Treatment of cancer chemotherapy-associated throm botic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer 1993;71:1882-1892.
7. Borghardt EJ, Kirchertz EJ, Marten I, Fenchel K. Protein Aimmunoadsorption in chemotherapy associated hemolytic-uremic syndrome. Transfus Sci 1998;19:5-7.
8. Wagner S, Janzen RW, Mohs C, Pohlmann S, Klingel R, Grützmacher PW. [Long-term treatment of refractory myasthenia gravis with immunoadsorption]. Dtsch Med Wochenschr 2008; 133:2377-2382.
9. Lüftl M, Stauber A, Mainka A, Klingel R, Schuler G, Hertl M. Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber. Br J Dermatol 2003;149:598-605.
10. Gaubitz M, Seidel M, Kummer S, Schotte H, Perniok A, Domschke W, Schneider M. Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus. J Autoimmun 1998;11:495-501.
11. Braun N, Risler T. Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease. Ther Apher 1999;3:240-245.
12. Felson DT, LaValley MP, Baldassare AR, Block JA, Caldwell JR, Cannon GW, Deal C, Evans S, Fleischmann R, Gendreau RM, Harris ER, Matteson EL, Roth SH, Schumacher HR, Weisman MH, Furst DE. The prosorba column for treatment of refractory rheumatoid arthritis: a randomized, doubleblind, sham-controlled trial. Arthritis Rheum 1999;42:2153-2159.
13. Wiesenhutter CW, Irish BL, Bertram JH. Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein A immunoadsorption columns: a pilot trial. J Rheumatol 1994; 21:804-812.
14. Caldwell J, Gendreau RM, Furst D, Wiesenhutter C, Quagliata F, Spindler J, Bertram J. A pilot study using a staph protein A column (Prosorba) to treat refractory rheumatoid arthritis. J Rheumatol 1999;26:1657-1662.
15. Schneider M, Berning T, Waldendorf M, Glaser J, Gerlach U. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus. J Rheumatol 1990;17:900-907.
16. Wallace DJ. Apheresis for lupus erythematosus. Lupus 1999;8: 174-180.
17. Deodhar A, Allen E, Daoud K, Wahba I. Vasculitis secondary to staphylococcal protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis. Semin Arthritis Rheum 2002;32:3-9.